HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy

被引：3

作者：

Guerveno, Claire ^{[1
]}

Raymond, Stephanie ^{[2
,3
]}

Metsu, David ^{[4
,5
]}

Gandia, Peggy ^{[4
,5
]}

Izopet, Jacques ^{[2
,3
]}

Martin-Blondel, Guillaume ^{[1
,3
]}

Delobel, Pierre ^{[1
,3
]}

机构：

[1] CHU Toulouse, Serv Malad Infect & Trop, Toulouse, France

[2] CHU Toulouse, Lab Virol, Toulouse, France

[3] INSERM, UMR1043, Toulouse, France

[4] CHU Toulouse, Lab Pharmacol Toxicol, Toulouse, France

[5] INRA, ENVT, INTHERES, Toulouse, France

来源：

AIDS | 2019年 / 33卷 / 03期

关键词：

DISOPROXIL FUMARATE;

D O I：

10.1097/QAD.0000000000002089

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：593 / 594

页数：2

共 6 条

[1] Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients [J].

Calcagno, Andrea ;

Simiele, Marco ;

Motta, Ilaria ;

Pinna, Simone Mornese ;

Bertucci, Roberto ;

D'Avolio, Antonio ;

Di Perri, Giovanni ;

Bonora, Stefano .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (05) :409-411

[2] Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods [J].

Metsu, David ;

Lanot, Thomas ;

Fraissinet, Francois ;

Picot, Melanie ;

Concordet, Didier ;

Cabrol, Marion ;

Dubois-Galopin, Frederique ;

Chatelut, Etienne ;

Delobel, Pierre ;

Gandia, Peggy .

CLINICA CHIMICA ACTA, 2018, 479 :56-65

[3] Development and validation of a UHPLC-MS/MS assay for elvitegravir measurement in human plasma and cerebrospinal fluid [J].

Ocque, Andrew Jacob ;

Hagler, Colleen E. ;

Lapham, Jill ;

Morse, Gene D. ;

Letendre, Scott ;

Ma, Qing .

SEPARATION SCIENCE PLUS, 2018, 1 (05) :325-333

[4] Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort [J].

Perrier, Marine ;

Charpentier, Charlotte ;

Peytavin, Gilles ;

Le, Minh ;

Blondel, Louis ;

Visseaux, Benoit ;

Joly, Veronique ;

Pinto, Adriana ;

Matheron, Sophie ;

Yazdanpanah, Yazdan ;

Descamps, Diane ;

Landman, Roland .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (06) :1745-1751

[5]

Rowland M., 2011, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications

[6] Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials [J].

Sax, Paul E. ;

Wohl, David ;

Yin, Michael T. ;

Post, Frank ;

DeJesus, Edwin ;

Saag, Michael ;

Pozniak, Anton ;

Thompson, Melanie ;

Podzamczer, Daniel ;

Molina, Jean Michel ;

Oka, Shinichi ;

Koenig, Ellen ;

Trottier, Benoit ;

Andrade-Villanueva, Jaime ;

Crofoot, Gordon ;

Custodio, Joseph M. ;

Plummer, Andrew ;

Zhong, Lijie ;

Cao, Huyen ;

Martin, Hal ;

Callebaut, Christian ;

Cheng, Andrew K. ;

Fordyce, Marshall W. ;

McCallister, Scott .

LANCET, 2015, 385 (9987) :2606-2615

← 1 →